Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Intervention1: Shwasahara mahakashaya avleha: Age in years Drug doses in
3 doses
5-7 6gm
8-10 9gm
11-13 12gm
14-15 15gm
ORAL
Sponsors
All India Institute of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: 1) Individuals of either gender between age group of 5 to 15 years. 2) Diagnosed cases of Tamaka Shwasa â??bronchial asthma with at least 3 episodes of asthma symptoms (cough, breathlessness) during the previous year. 3) Severity as mild to moderate stable bronchial asthma (Tamaka Shwasa) as per W.H.O GINA Guidelines. 4) Patient on other drug therapy will be included only after completion of the washout period of 3 weeks. 5) Parents giving consent to participate in study.
Exclusion criteria
Exclusion criteria: 1. Individuals below 5 years and above 15 years of age. 2. Sever case like status asthmaticus. 3. Evidence of active concomitants pulmonary disease other than asthma. 4. Evidence of requirement of intubation for asthma, or had been hospitalized for asthma within 1 month before. Had unresolved sinus disease or an unresolved upper or lower respiratory tract infection within 3 weeks. 5. More than 4 short courses of oral corticosteroids within the year preceding the screening visit or any oral corticosteroids in the preceding 4 weeks. 6. Concomitant severe decompensated systemic disease (cardiovascular, renal, hepatic, endocrine, haematological, neurological, immunological). 7. Patient/Parents not willing to participate in the study.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1-Asthma control questionaire 2-GINA asthma guidelines 3-Ayurvedic parameters like Dasavidha parikshya,Astasthana parikshya 4-pulmonary function test and peak expiratory flow examinationTimepoint: oday,60 day an one during follow up;1-Asthma control questionaire 2-GINA asthma guidelines 3-Ayurvedic parameters like Dasavidha parikshya,Astasthana parikshya 4-pulmonary function test and peak expiratory flow examinationTimepoint: oday,60 day an one during follow up | — |
Primary
| Measure | Time frame |
|---|---|
| 1. Improvement in classical sign and symptoms of Tamaka Shwasa. 2.Decrease in frequency, duration and severity of attacks.Timepoint: 0 day,15th day,30th day,45th day60th day | — |
Countries
India
Contacts
Public ContactDr Rajagopala Shrikrishna
All India Institute of Ayurveda
Outcome results
None listed